Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006416HBVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS10013548HBVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS30007328HIVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS20006681HPVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS20053670HPVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS20053637HPVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS20053865HPVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS20044906HPVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS20066147HPVENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TVIS44018113HTLV-1ENSG00000141639.12protein_codingMAPK4NoNo5596B4DEW2
K7ELV1
P31152
TCGA Plot Options
Drug Information
GeneMAPK4
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009476
UniProt IDP31152
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830